These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3526155)

  • 21. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
    Riikonen P
    Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
    Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
    Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
    Kinsey SE; Machin SJ; Goldstone AH
    J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
    Gaya H; Klastersky J; Schimpff SC; Tattersall MH
    Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
    [No Abstract]   [Full Text] [Related]  

  • 27. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M; Clavell LA
    P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
    Velasco E; Costa MA; Martins CA; Nucci M
    Am J Clin Oncol; 1995 Oct; 18(5):429-35. PubMed ID: 7572762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R; DePauw B; Berman S; Keating A; Ho W
    J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
    Cometta A; Calandra T; Gaya H; Zinner SH; de Bock R; Del Favero A; Bucaneve G; Crokaert F; Kern WV; Klastersky J; Langenaeken I; Micozzi A; Padmos A; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1996 May; 40(5):1108-15. PubMed ID: 8723449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
    ; Calandra T; Klastersky J; Gaya H; Glauser MP; Meunier F; Zinner SH
    N Engl J Med; 1987 Dec; 317(27):1692-8. PubMed ID: 2892130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftazidime in the treatment of febrile immunosuppressed children.
    Darbyshire PJ; Williamson PJ; Pedler SJ; Speller DC; Mott MG; Oakhill A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():357-60. PubMed ID: 6352644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fever, neutropenia and malignancy: a clinical syndrome in evolution.
    Pennington JE
    Cancer; 1977 Mar; 39(3):1345-9. PubMed ID: 912664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
    Rolston KV; Berkey P; Bodey GP; Anaissie EJ; Khardori NM; Joshi JH; Keating MJ; Holmes FA; Cabanillas FF; Elting L
    Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.